A carregar...
Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
BACKGROUND: Long-acting bronchodilators are central in the pharmacological management of patients with chronic obstructive pulmonary disease (COPD). The aim of this systematic review is to provide an overview of the studies evaluating the safety and clinical efficacy of inhaled glycopyrronium bromid...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3461699/ https://ncbi.nlm.nih.gov/pubmed/23055716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S35990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|